| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 113-48-4 | 增效胺; 协力克; N-(2-乙基己基)-双环(2,2,1)-5-庚烯-2,3-二甲酰亚胺 | N-(2-Ethylhexyl)-5-norbornene-2,3-dicarboximide; MGK 264; N-(2-Ethylhexyl)-bicyclo[2.2.1]hept-5-ene-2,3-dicarboximide |  | C17H25NO2 | 详情 | 供应商 |
| 52372-39-1 | 溶剂红197; 萤光红GK | Solvent Red 197; C.I. 505720; Fluorol Red GK; 3-(Diethylamino)-7-imino-7H-[1]benzopyrano[3',2':3,4]pyrido[1,2-a]benzimidazole-6-carbonitrile |  | C23H19N5O | 详情 | 供应商 |
| 35065-59-9 | Glycine, N-chloro-; GK 101; Glycine chloramine; N-Chloroglycine |  | C2H4ClNO2 | 详情 | 供应商 | |
| 86073-75-8 | L-Argininamide,D-valyl-3-cyclohexyl-L-alanyl-N-(4-nitrophenyl)-; ChromozymGK |  | C26H42N8O5 | 详情 | 供应商 | |
| 15491-86-8 | Picromerite(MgK2(SO4)2.6H2O) (9CI); Picromerite(8CI); Schoenite |  | H2O4S.3H2O.K.1/2Mg | 详情 | 供应商 | |
| 21500-98-1 | Piperidine,1-[1-(2-thienyl)cyclohexyl]-; GK 0; N-[1-(2-Thienyl)cyclohexyl]piperidine; TCP; Tenocyclidine; Thienylcyclidine; Thienylphencyclidine |  | C15H23NS | 详情 | 供应商 | |
| 306935-13-7 | 2-Thiophenecarboxamide,3-amino-5-[4-(1,1-dimethylethyl)phenyl]-; GK 03408 |  | C15H18N2OS | 详情 | 供应商 | |
| 304896-28-4 | 2-Propenamide,2-cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-; AGK 2 |  | C23H13Cl2N3O2 | 详情 | 供应商 | |
| 11076-19-0 | 米酵菌酸 | BONGKREKIC ACID; (r-(r*,s*(e,z,z,e,e,z,e)))--trimethyl; 2,4,8,10,14,18,20-docosaheptaenedioicacid,20-(carboxymethyl)-6-methoxy-2,5,17; 3-carboxymethyl-17-methoxy-6,18,21-trimethyldocosa-2,4,8,12,14,18,20-heptaen; edioicacid; BONGKREKIC ACID; bongkrekic acid solution; (2E,4Z,6R,8Z,10E,14E,17S,18Z,20E)-20-Carboxymethyl-6-methoxy-2,5,17-trimethyldocosa-2,4,8,10,14,18,20-heptaenedioic acid |  | C28H42O3 | 详情 | 供应商 |
| 143748-18-9 | PACAP (6-38), HUMAN, OVINE, RAT | H-PHE-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-AR; FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; HIS-SER-ASP-GLY-ILE-PHE-THR-AP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2; H-PHE-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2; PHE-THR-ASP-SER-TYR-SER-ARG-TYR-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ALA-ALA-VAL-LEU-GLY-LYS-ARG-TYR-LYS-GLN-ARG-VAL-LYS-ASN-LYS-NH2; PITUITARY ADENYLATE ACTIVATING POLYPEPTIDE (6-38) (HUMAN, OVINE, RAT); PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (6-38), HUMAN, OVINE, RAT; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38 (6-38) (HUMAN, CHICKEN, MOUSE, OVINE, PORCINE, RAT); PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE (6-38) AMIDE (HUMAN, OVINE, RAT) |  | C203H331N63O65S | 详情 | 供应商 |
| 128578-18-7 | ASP-PRO-MET-SER-SER-THR-TYR-ILE-GLU-GLU-LEU-GLY-LYS-ARG-GLU-VAL-THR-ILE-PRO-PRO-LYS-TYR-ARG-GLU-LEU- | CALPAIN INHIBITOR PEPTIDE; DPMSSTYIEELGKREVTIPPKYRELLA; H-ASP-PRO-MET-SER-SER-THR-TYR-ILE-GLU-GLU-LEU-GLY-LYS-ARG-GLU-VAL-THR-ILE-PRO-PRO-LYS-TYR-ARG-GLU-LEU-LEU-ALA-OH; ASP-PRO-MET-SER-SER-THR-TYR-ILE-GLU-GLU-LEU-GLY-LYS-ARG-GLU-VAL-THR-ILE-PRO-PRO-LYS-TYR-ARG-GLU-LEU-LEU-ALA; CALPAIN INHIBITOR PEPTIDE; CALPAIN INHIBITOR PEPTIDE, B27-WT |  | C140H227N35O44S | 详情 | 供应商 |
| 1243244-14-5 | LGK-974 | 无 | 详情 | 供应商 | ||
| 112540-82-6 | ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 无 | C180H287N57O48 | 详情 | 供应商 |
| 114679-42-4 | ALA-CYS-ASN-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA- ASP-PHE-LEU-SER-ARG-SER-GLY-GLY-VAL-GLY-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2(DISULFIDE BRIDGE CYS2-CYS7); ALA-CYS-ASN-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA- ASP-PHE-LEU-SER-ARG-SER-GLY-GLY-VAL-GLY-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2(DISULFIDE BRIDGE CYS2-CYS7); ALA-CYS-ASN-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-ASP-PHE-LEU-SER-ARG-SER-GLY-GLY-VAL-GLY-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2; GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2: GGVVKNNFVPTNVGSKAF-NH2 | CGRP (CHICKEN); ACNTATCVTHRLADFLSRSGGVGKNNFVPTNVGSKAF-NH2 (DISULFIDE BRIDGE: 2-7); CALCITONIN GENE-RELATED PEPTIDES (CHICKEN); CALCITONIN GENE RELATED PEPTIDE, CHICKEN; CGRP (CHICKEN); H-ALA-CYS-ASN-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-ASP-PHE-LEU-SER-ARG-SER-GLY-GLY-VAL-GLY-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2; H-ALA-CYS-ASN-THR-ALA-THR-CYS-VAL-THR-HIS-ARG-LEU-ALA-ASP-PHE-LEU-SER-ARG-SER-GLY-GLY-VAL-GLY-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2 (DISULFIDE BRIDGE: 2-7); H-Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Asp-Phe-Leu-Ser-Arg-Ser-Gly-Gly-Val-Gly-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | 无 | C165H260N52O50S2 | 详情 | 供应商 |
sitemap.xml